首页> 外文期刊>American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons >Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation.
【24h】

Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation.

机译:肝移植后的生存结果(SOFT)评分:一种预测肝移植后患者生存率的新方法。

获取原文
获取原文并翻译 | 示例
       

摘要

It is critical to balance waitlist mortality against posttransplant mortality. Our objective was to devise a scoring system that predicts recipient survival at 3 months following liver transplantation to complement MELD-predicted waitlist mortality. Univariate and multivariate analysis on 21,673 liver transplant recipients identified independent recipient and donor risk factors for posttransplant mortality. A retrospective analysis conducted on 30,321 waitlisted candidates reevaluated the predictive ability of the Model for End-Stage Liver Disease (MELD) score. We identified 13 recipient factors, 4 donor factors and 2 operative factors (warm and cold ischemia) as significant predictors of recipient mortality following liver transplantation at 3 months. The Survival Outcomes Following Liver Transplant (SOFT) Score utilized 18 risk factors (excluding warm ischemia) to successfully predict 3-month recipient survival following liver transplantation. This analysis represents a study of waitlisted candidatesand transplant recipients of liver allografts after the MELD score was implemented. Unlike MELD, the SOFT score can accurately predict 3-month survival following liver transplantation. The most significant risk factors were previous transplantation and life support pretransplant. The SOFT score can help clinicians determine in real time which candidates should be transplanted with which allografts. Combined with MELD, SOFT can better quantify survival benefit for individual transplant procedures.
机译:在候补死亡率和移植后死亡率之间取得平衡至关重要。我们的目标是设计一个评分系统,该系统可预测肝移植后3个月的受体存活情况,以补充MELD预测的候补名单死亡率。对21673例肝移植受者的单因素和多因素分析确定了移植后死亡率的独立受者和供体危险因素。对30321名候补候选人进行的回顾性分析重新评估了终末期肝病模型(MELD)评分的预测能力。我们确定了13个受体因素,4个供体因素和2个手术因素(冷,热缺血)作为3个月肝移植术后接受者死亡率的重要预测指标。肝移植(SOFT)评分后的生存结果利用18个危险因素(不包括热缺血)成功预测了肝移植后3个月的受体存活。该分析代表了对实施MELD评分后的候补候选人和同种异体肝移植接受者的研究。与MELD不同,SOFT评分可以准确预测肝移植后3个月的存活率。最重要的危险因素是先前的移植和生命支持移植前。 SOFT评分可以帮助临床医生实时确定应使用哪些同种异体移植哪些候选人。结合MELD,SOFT可以更好地量化单个移植程序的生存获益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号